Fulcrum Therapeutics Inc (NASDAQ: FULC) Is Getting Increasingly Hard To Ignore
Currently, there are 61.92M common shares owned by the public and among those 57.73M shares have been available to trade. However, the script later moved the day high at 3.8080, up 9.75%. The company’s stock has a 5-day price change of -58.60% and -50.14% over the past three months. FULC shares are trading -48.30% year […]
Assessing Whether Fulcrum Therapeutics Inc (NASDAQ: FULC) Is Over- Or Undervalued
Fulcrum Therapeutics Inc (FULC) concluded trading on Thursday at a closing price of $3.44, with 34.24 million shares of worth about $117.8 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -69.72% during that period and on September 12, 2024 the price saw a […]
Look At Analyst Expectations For A Better Read On Fulcrum Therapeutics Inc (NASDAQ: FULC)
Currently, there are 61.92M common shares owned by the public and among those 57.71M shares have been available to trade. The company’s stock has a 5-day price change of -6.76% and 8.92% over the past three months. FULC shares are trading 26.67% year to date (YTD), with the 12-month market performance up to 51.33% higher. […]
